Antiretroviral drug resistance and risk behavior among recently HIV-infected men who have sex with men

Journal of Acquired Immune Deficiency Syndromes

Volumn 47, Issue 5, 2008, Pages 639-643

  Gorbach, Pamina M ^a,f   Drumright, Lydia N ^b   Javanbakht, Marjan ^a   Pond, Sergei L ^b   Woelk, Christopher H ^b   Daar, Eric S ^c,d   Little, Susan J ^e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c HARBOR UCLA MEDICAL CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

HIV antiviral resistance; Men who have sex with men; Sexual behavior; Substance use

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; 4 HYDROXYBUTYRIC ACID; ANTIRETROVIRUS AGENT; METHAMPHETAMINE;

ADULT; ARTICLE; CAUCASIAN; GENOTYPE; HISPANIC; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MALE HOMOSEXUAL; PHENOTYPE; PRIORITY JOURNAL; QUESTIONNAIRE; SEXUAL BEHAVIOR; SUBSTANCE ABUSE;

ADULT; DRUG RESISTANCE, VIRAL; HIV; HIV INFECTIONS; HOMOSEXUALITY, MALE; HUMANS; MALE; METHAMPHETAMINE; QUESTIONNAIRES; RISK FACTORS; RISK-TAKING; SUBSTANCE ABUSE, INTRAVENOUS; SUBSTANCE-RELATED DISORDERS;

EID: 41149159637     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3181684c3d     Document Type: Article

References (24)

1. Shet A, Berry L, Mohri H, et al. Tracking the prevalence of transmitted antiretroviral drug-resistant HIV-1: a decade of experience. J Acquir Immune Defic Syndr. 2006;41:439-446.
2. Jayaraman GC, Archibald CP, Kim J, et al. A population-based approach to determine the prevalence of transmitted drug-resistant HIV among recent versus established HIV infections: results from the Canadian HIV strain and drug resistance surveillance program. J Acquir Immune Defic Syndr. 2006;42:86-90.
3. von WV, Yerly S, Boni J, et al. Emergence of HIV-1 drug resistance in previously untreated patients initiating combination antiretroviral treatment: a comparison of different regimen types. Arch Intern Med. 2007;167:1782-1790.
4. Booth CL, Geretti AM. Prevalence and determinants of transmitted antiretroviral drug resistance in HIV-1 infection. J Antimicrob Chemother. 2007;59:1047-1056.
5. Blower S, Aschenbach A, Gershengorn H, et al. Predicting the unpredictable: transmission of drug-resistant HIV. Nat Med. 2001;7:1016-1020.
6. Markowitz M, Mohri H, Mehandru S, et al. Infection with multidrug resistant, dual-tropic HIV-1 and rapid progression to AIDS: a case report. Lancet. 2005;365:1031-1038.
7. Colfax G, Vittinghoff E, Husnik MJ, et al. Substance use and sexual risk: a participant- and episode-level analysis among a cohort of men who have sex with men. Am J Epidemiol. 2004;159:1002-1012.
8. Klitzman RL, Pope HG Jr, Hudson JI. MDMA ("Ecstasy") abuse and high-risk sexual behaviors among 169 gay and bisexual men. Am J Psychiatry. 2000;157:1162-1164.
9. Purcell DW, Parsons JT, Halkitis PN, et al. Substance use and sexual transmission risk behavior of HIV-positive men who have sex with men. J Subst Abuse. 2001;13:185-200.
10. Buchbinder SP, Vittinghoff E, Heagerty PJ, et al. Sexual risk, nitrite inhalant use, and lack of circumcision associated with HIV seroconversion in men who have sex with men in the United States. J Acquir Immune Defic Syndr. 2005;39:82-89.
11. Hirshfield S, Remien RH, Walavalkar I, et al. Crystal methamphetamine use predicts incident STD infection among men who have sex with men recruited online: a nested case-control study. J Med Internet Res. 2004;6:e41.
12. Tabet SR, Krone MR, Paradise MA, et al. Incidence of HIV and sexually transmitted diseases (STD) in a cohort of HIV-negative men who have sex with men (MSM). AIDS. 1998;12:2041-2048.
13. Thiede H, Valleroy LA, MacKellar DA, et al. Regional patterns and correlates of substance use among young men who have sex with men in 7 US urban areas. Am J Public Health. 2003;93:1915-1921.
14. Beckett M, Burnam A, Collins RL, et al. Substance use and high-risk sex among people with HIV: a comparison across exposure groups. AIDS Behav. 2003;7:209-219.
15. CDC. Increases in HIV diagnoses - 29 states, 1999-2002. MMWR Morb Mortal Wkly Rep. 2003;52:1145-1148.
16. Stall R, Paul JP, Greenwood G, et al. Alcohol use, drug use and alcohol-related problems among men who have sex with men: the Urban Men's Health Study. Addiction. 2001;96:1589-1601.
17. Colfax GN, Vittinghoff E, Grant R, et al. Frequent methamphetamine use is associated with primary non-nucleoside reverse transcriptase inhibitor resistance. AIDS. 2007;21:239-241.
18. Gorbach PM, Drumright LN, Daar ES, et al. Transmission behaviors of recently HIV-infected men who have sex with men. J Acquir Immune Defic Syndr. 2006;42:80-85.
19. Drumright LN, Little SJ, Strathdee SA, et al. Unprotected anal intercourse and substance use among men who have sex with men with recent HIV infection. J Acquir Immune Defic Syndr. 2006;43:344-350.
20. Peteropoulos C, Parkin N, Limoli K, et al. A novel phenotypic drug susceptibility assay for human immunodeficiency virus type 1. Antimicrob Agents Chemother. 2000;44:920-928.
21. Parkin N, Hellman N, Whitcomb J, et al. Natural variation of drug susceptibility in wild-type human immunodeficiency virus type 1. Antimicrob Agents Chemother. 2004;48:437-443.
22. Drumright LN, Gorbach PM, Holmes KK. Do people really know their sex partners? Concurrency, knowledge of partner behavior, and sexually transmitted infections within partnerships. Sex Transm Dis. 2004;31:437-442.
23. Harrigan PR, Hogg RS, Dong WW, et al. Predictors of HIV drug-resistance mutations in a large antiretroviral-naive cohort initiating triple antiretroviral therapy. J Infect Dis. 2005;191:339-347.
24. Sullivan P, Nakashima A, Purcell D, et al. Geographic differences in noninjection and injection substance use among HIV-seropositive men who have sex with men: western United States versus other regions. Supplement to HIV/AIDS Surveillance Study Group. J Acquir Immune Defic Syndr Hum Retrovirol. 1998;19:266-273.